Typicality: | 0.317 |
Saliency: | 0.157 |
as a phase iii trial | 2 | manner |
trial → be published in → peer-reviewed journals | 5 |
trial → be published in → peer-reviewed journal | 3 |
negative | neutral | positive |
0.022 | 0.768 | 0.210 |
Raw frequency | 8 |
Normalized frequency | 0.157 |
Modifier score | 0.500 |
Perplexity | 8.683 |